{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:14:33Z","timestamp":1789560873229,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jtos.2024.08.008","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T17:50:12Z","timestamp":1723139412000},"page":"225-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Duloxetine enhances PAX6 expression and suppresses innate immune responses in murine LPS-induced corneal inflammation"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3192-3708","authenticated-orcid":false,"given":"Petros","family":"Moustardas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojdeh","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Javidjam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy Saah","family":"Asamoah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Schweitzer-Chaput","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Cisternino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Bremond-Gignac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Aberdam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1079-4361","authenticated-orcid":false,"given":"Neil","family":"Lagali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtos.2024.08.008_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jtos.2021.09.001","article-title":"Pathophysiology of aniridia-associated keratopathy: developmental aspects and unanswered questions","volume":"22","author":"Latta","year":"2021","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2024.08.008_bib60","doi-asserted-by":"crossref","unstructured":"Daruich A, Duncan M, Robert MP, Lagali N, Semina EV, Aberdam D, Ferrari S, Romano V, des Roziers CB, Benkortebi R, De Vergnes N, Polak M, Chiambaretta F, Nischal KK, Behar-Cohen F, Valleix S, Bremond-Gignac D. Congenital aniridia beyond black eyes: From phenotype and novel genetic mechanisms to innovative therapeutic approaches. Prog Retin Eye Res. 2023 Jul;95:101133. doi: 10.1016\/j.preteyeres.2022.101133. Epub 2022 Oct 22. PMID: 36280537; PMCID: PMC11062406.","DOI":"10.1016\/j.preteyeres.2022.101133"},{"issue":"12","key":"10.1016\/j.jtos.2024.08.008_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/genes10121050","article-title":"The spectrum of PAX6 mutations and genotype-phenotype correlations in the eye","volume":"10","author":"Lima Cunha","year":"2019","journal-title":"Genes"},{"key":"10.1016\/j.jtos.2024.08.008_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2022.101133","article-title":"Congenital aniridia beyond black eyes: from phenotype and novel genetic mechanisms to innovative therapeutic approaches","volume":"95","author":"Daruich","year":"2023","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"10.1016\/j.jtos.2024.08.008_bib4","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jtos.2019.11.002","article-title":"Early phenotypic features of aniridia-associated keratopathy and association with PAX6 coding mutations","volume":"18","author":"Lagali","year":"2020","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.jtos.2024.08.008_bib5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/bjo-2021-320774","article-title":"Early ocular surface and tear film status in congenital aniridia indicates a supportive treatment window","volume":"108","author":"Fries","year":"2023","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2024.08.008_bib6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bbrc.2021.10.036","article-title":"Ritanserin, a potent serotonin 2A receptor antagonist, represses MEK\/ERK signalling pathway to restore PAX6 production and function in aniridia-like cellular model","volume":"582","author":"Oved","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jtos.2024.08.008_bib7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jtos.2021.12.003","article-title":"The antipsychotropic drug Duloxetine rescues PAX6 haploinsufficiency of mutant limbal stem cells through inhibition of the MEK\/ERK signaling pathway","volume":"23","author":"Dorot","year":"2022","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2024.08.008_bib8","series-title":"Cymbalta (duloxetine hydrochloride) [package insert] Indianapolis","author":"Company","year":"2011"},{"issue":"5","key":"10.1016\/j.jtos.2024.08.008_bib9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/11539240-000000000-00000","article-title":"Duloxetine: clinical pharmacokinetics and drug interactions","volume":"50","author":"Knadler","year":"2011","journal-title":"Clin Pharmacokinet"},{"issue":"3\u20134","key":"10.1016\/j.jtos.2024.08.008_bib10","first-page":"37","article-title":"Serotonin norepinephrine reuptake inhibitors: a pharmacological comparison","volume":"11","author":"Sansone","year":"2014","journal-title":"Innov Clin Neurosci"},{"key":"10.1016\/j.jtos.2024.08.008_bib11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/7854_2012_216","article-title":"Molecular and cellular mechanisms of antidepressant action","volume":"14","author":"Sharp","year":"2013","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.jtos.2024.08.008_bib12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.phrs.2018.06.015","article-title":"Beyond a neurotransmitter: the role of serotonin in inflammation and immunity","volume":"140","author":"Wu","year":"2019","journal-title":"Pharmacol Res"},{"issue":"1","key":"10.1016\/j.jtos.2024.08.008_bib13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.intimp.2014.02.030","article-title":"Selective serotonin reuptake inhibitors as a novel class of immunosuppressants","volume":"20","author":"Gobin","year":"2014","journal-title":"Int Immunopharm"},{"issue":"1\u20132","key":"10.1016\/j.jtos.2024.08.008_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jneuroim.2008.03.012","article-title":"Serotonin transporter is differentially localized in subpopulations of lymphocytes of major depression patients. Effect of fluoxetine on proliferation","volume":"196","author":"Fazzino","year":"2008","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jtos.2024.08.008_bib15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fcvm.2017.00048","article-title":"The effects of serotonin in immune cells","volume":"4","author":"Herr","year":"2017","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"10.1016\/j.jtos.2024.08.008_bib16","first-page":"4195","article-title":"Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis","volume":"55","author":"K\u00f6hler","year":"2018","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.jtos.2024.08.008_bib17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pharmthera.2016.04.001","article-title":"Antidepressant therapies inhibit inflammation and microglial M1-polarization","volume":"163","author":"Kalkman","year":"2016","journal-title":"Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.jtos.2024.08.008_bib18","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1007\/s00213-022-06194-6","article-title":"Duloxetine ameliorates lipopolysaccharide-induced microglial activation by suppressing iNOS expression in BV-2 microglial cells","volume":"239","author":"Nakatani","year":"2022","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.jtos.2024.08.008_bib19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.stemcr.2021.12.009","article-title":"PAX6-positive microglia evolve locally in hiPSC-derived ocular organoids","volume":"17","author":"Shiraki","year":"2022","journal-title":"Stem Cell Rep"},{"issue":"14","key":"10.1016\/j.jtos.2024.08.008_bib20","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1128\/MCB.22.14.5157-5172.2002","article-title":"A two-stage, p16(INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status","volume":"22","author":"Rheinwald","year":"2002","journal-title":"Mol Cell Biol"},{"issue":"6","key":"10.1016\/j.jtos.2024.08.008_bib21","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1167\/iovs.02-0851","article-title":"Mucin gene expression in immortalized human corneal-limbal and conjunctival epithelial cell lines","volume":"44","author":"Gipson","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.jtos.2024.08.008_bib22","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/stem.2858","article-title":"Modeling of aniridia-related keratopathy by CRISPR\/Cas9 genome editing of human limbal epithelial cells and rescue by recombinant PAX6 protein","volume":"36","author":"Roux","year":"2018","journal-title":"Stem Cell"},{"issue":"7","key":"10.1016\/j.jtos.2024.08.008_bib23","first-page":"2278","article-title":"Regulation of endotoxin-induced keratitis by PECAM-1, MIP-2, and toll-like receptor 4","volume":"43","author":"Khatri","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.jtos.2024.08.008_bib24","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1189\/jlb.0806502","article-title":"CXCL1\/KC and CXCL5\/LIX are selectively produced by corneal fibroblasts and mediate neutrophil infiltration to the corneal stroma in LPS keratitis","volume":"81","author":"Lin","year":"2007","journal-title":"J Leukoc Biol"},{"issue":"6","key":"10.1016\/j.jtos.2024.08.008_bib25","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1517\/14740338.4.6.987","article-title":"Safety and adverse event profile of duloxetine","volume":"4","author":"Wernicke","year":"2005","journal-title":"Expet Opin Drug Saf"},{"issue":"1","key":"10.1016\/j.jtos.2024.08.008_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/da.20209","article-title":"Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation","volume":"24","author":"Wohlreich","year":"2007","journal-title":"Depress Anxiety"},{"issue":"5","key":"10.1016\/j.jtos.2024.08.008_bib27","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/hup.696","article-title":"Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials","volume":"20","author":"Hudson","year":"2005","journal-title":"Hum Psychopharmacol"},{"issue":"3","key":"10.1016\/j.jtos.2024.08.008_bib28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/00003088-200948030-00005","article-title":"Population pharmacokinetics of orally administered duloxetine in patients: implications for dosing recommendation","volume":"48","author":"Lobo","year":"2009","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"10.1016\/j.jtos.2024.08.008_bib29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1055\/s-0029-1220890","article-title":"Duloxetine serum concentrations and clinical effects. Data from a therapeutic drug monitoring (TDM) survey","volume":"42","author":"Waldschmitt","year":"2009","journal-title":"Pharmacopsychiatry"},{"issue":"573","key":"10.1016\/j.jtos.2024.08.008_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz4894","article-title":"Gene dosage manipulation alleviates manifestations of hereditary PAX6 haploinsufficiency in mice","volume":"12","author":"Rabiee","year":"2020","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.jtos.2024.08.008_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/cells12040617","article-title":"MAPK pathways in ocular pathophysiology: potential therapeutic drugs and challenges","volume":"12","author":"Moustardas","year":"2023","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.jtos.2024.08.008_bib32","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nri2800","article-title":"Innate IL-17-producing cells: the sentinels of the immune system","volume":"10","author":"Cua","year":"2010","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.jtos.2024.08.008_bib33","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2013.03.030","article-title":"Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease","volume":"153","author":"Zhang","year":"2013","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.jtos.2024.08.008_bib34","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1161\/ATVBAHA.108.173898","article-title":"Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability","volume":"28","author":"Newby","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.jtos.2024.08.008_bib35","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1189\/jlb.0306152","article-title":"Matrix metalloproteinases, their production by monocytes and macrophages and their potential role in HIV-related diseases","volume":"80","author":"Webster","year":"2006","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jtos.2024.08.008_bib36","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/978-1-59745-396-7_16","article-title":"Analysis of matrix metalloproteinase secretion by macrophages","volume":"531","author":"Elkington","year":"2009","journal-title":"Methods Mol Biol"},{"issue":"4","key":"10.1016\/j.jtos.2024.08.008_bib37","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1006\/jmbi.2000.4235","article-title":"Macrophages secrete matrix metalloproteinase 9 covalently linked to the core protein of chondroitin sulphate proteoglycans","volume":"304","author":"Winberg","year":"2000","journal-title":"J Mol Biol"},{"issue":"9","key":"10.1016\/j.jtos.2024.08.008_bib38","doi-asserted-by":"crossref","first-page":"5661","DOI":"10.1128\/IAI.69.9.5661-5670.2001","article-title":"Production of matrix metalloproteinases in response to mycobacterial infection","volume":"69","author":"Quiding-J\u00e4rbrink","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.jtos.2024.08.008_bib39","first-page":"Unit14","article-title":"Measuring matrix metalloproteinase activity in macrophages and polymorphonuclear leukocytes","volume":"14","author":"Kessenbrock","year":"2011","journal-title":"Curr Protoc Immunol Chapter"},{"key":"10.1016\/j.jtos.2024.08.008_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.663978","article-title":"Matrix metalloproteinase 3: a promoting and destabilizing factor in the pathogenesis of disease and cell differentiation","volume":"12","author":"Wan","year":"2021","journal-title":"Front Physiol"},{"issue":"31","key":"10.1016\/j.jtos.2024.08.008_bib41","doi-asserted-by":"crossref","first-page":"19158","DOI":"10.1074\/jbc.M114.634022","article-title":"A novel role of matrix metalloproteinase-8 in macrophage differentiation and polarization","volume":"290","author":"Wen","year":"2015","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.jtos.2024.08.008_bib42","first-page":"1779","article-title":"Expression of collagenolytic\/gelatinolytic metalloproteinases by normal cornea","volume":"31","author":"Fini","year":"1990","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.jtos.2024.08.008_bib43","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1038\/s41467-021-22973-9","article-title":"The neutrotime transcriptional signature defines a single continuum of neutrophils across biological compartments","volume":"12","author":"Grieshaber-Bouyer","year":"2021","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.jtos.2024.08.008_bib44","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1067\/mai.2003.1594","article-title":"Chemokines: roles in leukocyte development, trafficking, and effector function","volume":"111","author":"Ono","year":"2003","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.jtos.2024.08.008_bib45","doi-asserted-by":"crossref","first-page":"245","DOI":"10.33549\/physiolres.930448","article-title":"Calprotectin - a pleiotropic molecule in acute and chronic inflammation","volume":"53","author":"Str\u00edz","year":"2004","journal-title":"Physiol Res"},{"key":"10.1016\/j.jtos.2024.08.008_bib46","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3389\/fimmu.2018.01298","article-title":"S100A8\/A9 in inflammation","volume":"9","author":"Wang","year":"2018","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.jtos.2024.08.008_bib47","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1021\/cb500792b","article-title":"Manganese and microbial pathogenesis: sequestration by the Mammalian immune system and utilization by microorganisms","volume":"10","author":"Brophy","year":"2015","journal-title":"ACS Chem Biol"},{"issue":"10","key":"10.1016\/j.jtos.2024.08.008_bib48","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nchembio.1891","article-title":"Human calprotectin is an iron-sequestering host-defense protein","volume":"11","author":"Nakashige","year":"2015","journal-title":"Nat Chem Biol"},{"issue":"10","key":"10.1016\/j.jtos.2024.08.008_bib49","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1136\/gutjnl-2021-324855","article-title":"Calprotectin: from biomarker to biological function","volume":"70","author":"Jukic","year":"2021","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.jtos.2024.08.008_bib50","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00011-023-01757-5","article-title":"A positive feedback cycle between the alarmin S100A8\/A9 and NLRP3 inflammasome-GSDMD signalling reinforces the innate immune response in Candida albicans keratitis","volume":"72","author":"Fang","year":"2023","journal-title":"Inflamm Res"},{"key":"10.1016\/j.jtos.2024.08.008_bib51","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.2147\/OPTH.S389780","article-title":"Calprotectin as a biomarker for diagnosis and severity of acute noninfectious anterior uveitis in Egyptian patients","volume":"16","author":"Abd El Meged Nage","year":"2022","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"10.1016\/j.jtos.2024.08.008_bib52","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1080\/09273948.2018.1485956","article-title":"The expression of calprotectin and factors in TLR4\/NF-\u03baB\/MyD88 pathway in patients with idiopathic acute anterior uveitis","volume":"27","author":"Song","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"issue":"8","key":"10.1016\/j.jtos.2024.08.008_bib53","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1080\/02713683.2020.1867749","article-title":"The role of plasma calprotectin in non-infectious uveitis","volume":"46","author":"Pascual","year":"2021","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jtos.2024.08.008_bib54","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3389\/fimmu.2020.00528","article-title":"The chemokine receptor CCR7 Uses distinct signaling modules with biased functionality to regulate dendritic cells","volume":"11","author":"Rodr\u00edguez-Fern\u00e1ndez","year":"2020","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.jtos.2024.08.008_bib55","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1177\/1060028014529645","article-title":"Probable association of an attack of bilateral acute angle-closure glaucoma with duloxetine","volume":"48","author":"Shifera","year":"2014","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.jtos.2024.08.008_bib56","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1089\/jop.2017.0133","article-title":"How does usage of serotonin noradrenaline reuptake inhibitors affect intraocular pressure in depression patients?","volume":"34","author":"U\u00e7an G\u00fcnd\u00fcz","year":"2018","journal-title":"J Ocul Pharmacol Therapeut"},{"issue":"9\u201310","key":"10.1016\/j.jtos.2024.08.008_bib57","first-page":"358","article-title":"Bilateral acute angle-closure glaucoma induced by duloxetine","volume":"70","author":"Mahmut","year":"2017","journal-title":"Ideggyogyaszati Szle"},{"issue":"1","key":"10.1016\/j.jtos.2024.08.008_bib58","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10792-022-02396-1","article-title":"Evaluation of the effects of duloxetine treatment on anterior segment parameters by optical coherence tomography","volume":"43","author":"\u00d6zer","year":"2023","journal-title":"Int Ophthalmol"},{"issue":"8","key":"10.1016\/j.jtos.2024.08.008_bib59","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41434-018-0043-6","article-title":"Epistasis between Pax6(Sey) and genetic background reinforces the value of defined hybrid mouse models for therapeutic trials","volume":"25","author":"Hickmott","year":"2018","journal-title":"Gene Ther"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012424000867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012424000867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T06:03:45Z","timestamp":1733465025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012424000867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":60,"alternative-id":["S1542012424000867"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2024.08.008","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Duloxetine enhances PAX6 expression and suppresses innate immune responses in murine LPS-induced corneal inflammation","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2024.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}